Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Cancer Science|June 7, 2024
Human papillomavirus-driven head and neck cancers in Japan during 2008-2009 and 2018-2019: The BROADEN studyKen-Ichi Nibu, Nobuhiko Oridate, Yuki Saito, et al.
Head & Neck|August 16, 2019
Absence of disruptive TP53 mutations in high-risk human papillomavirus-driven neck squamous cell carcinoma of unknown primaryPaolo Boscolo-Rizzo, Lea Schroeder, Valeria Sacchetto, et al.
Oral Oncology|December 27, 2023
Detection of serum biomarkers of HPV-16 driven oropharynx and oral cavity cancer in BrazilLaura Sichero, Milena Giulia Gonçalves, Fabiana Bettoni, et al.
International Journal of Cancer|August 14, 2019
Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus statusDominik S Gangkofner, Dana Holzinger, Lea Schroeder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2019
Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma PatientsSimon Laban, Dominik S Gangkofner, Dana Holzinger, et al.
International Journal of Cancer|May 29, 2019
Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancerKatrin Schmitt, Britta Molfenter, Natalia Koerich Laureano, et al.
International Journal of Cancer|September 11, 2023
Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sexJohannes M A Kusters, Brenda Diergaarde, Andrew Ness, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2022
Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort ConsortiumHilary A Robbins, Aida Ferreiro-Iglesias, Tim Waterboer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 2, 2026
Genetically proxied inhibition of cholesterol-lowering drug targets and survival in HPV-positive and non-HPV driven head and neck cancer: a multicentre MR studyDanni Cheng, Katrina Hueniken, Tianzhichao Hou, et al.
Nature Communications|October 13, 2021
Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancerAida Ferreiro-Iglesias, James D McKay, Nicole Brenner, et al.
Pageof 4